Recent in vitro studies using patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from DM1 patients have shown that NaV1.5 dysfunction reduces current density and slows depolarization and conduction velocity, increasing arrhythmogenic potential [80,83]. The gene discussed is SCN5A; the disease is myotonic dystrophy type 1.